Michael Alexiades, M.D., an orthopedic surgeon at Hospital for Special Surgery (HSS) in New York, has been appointed to the Scientific Advisory Board (SAB) of Ontario, Canada-based Intellijoint Surgical Inc.. All of Dr. Alexiades’ 29 years in practice have been spent at HSS.
Michael Alexiades, M.D. Joins Intellijoint Advisory Board

A hip, knee, shoulder and elbow specialist, Dr. Alexiades has been in the forefront of the mini-anterior approach to total hip arthroplasty and was an early adopter of the partial knee replacement. In the last two years, Dr. Alexiades has completed hundreds of THAs using Intellijoint HIP to deliver the best possible outcomes for his patients.
“Dr. Alexiades was an essential team member in the development of Intellijoint HIP for the anterior approach,” explained Armen Bakirtzian, company CEO and co-founder. “His experience, knowledge and keen interest in developing technology to improve total joint replacement outcomes is an invaluable asset and I am so happy he is expanding his role by joining our SAB.”
Dr. Alexiades is active in New York’s Finest Foundation, chairs the NYPD Article II Medical Board and is Chief Surgeon for the NY State Troopers Association. He is actively involved in resident and fellow education and is an examiner for the American Board of Orthopedic Surgery.
Dr. Alexiades told OTW, Intellijoint HIP is a novel navigation system which addresses the main problem points of traditional navigation—complexity, size, cost, speed and work flow—while adding highly accurate, intraoperative measurements for implant positioning during total hip replacements. I joined Intellijoint Surgical’s Scientific Advisory Board to be a part of the driving force to bring this advanced navigation system to other surgical applications. This, along with clinical research and surgeon education, will be my main focus as I start this new role.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.